Jeffrey L. Ives, PhD, is a partner with New Leaf Venture Partners and an entrepreneur and CEO with over 30 years of experience building successful research organizations and delivering important new clinical candidates and products. He serves as an independent director on several biotechnology companies and consults with industry, reviewing ongoing internal programs, identifying new research programs and external collaborations, and performing scientific due diligences for clients in medicinal chemistry, drug metabolism and preclinical development.
From 2008 until 2013, Dr. Ives served as the CEO of Satori Pharmaceuticals, Inc., a company focused on Alzheimer’s disease. Prior to Satori, he served as senior vice president at Pfizer, leading the neurodegenerative diseases, psychiatry and pain research areas. Dr. Ives received his doctorate and master’s degrees from Yale University and received his BA from Colgate University.